A collection of engaging infographics from healthcare influencers to capture trends in emerging groups of pharmaceuticals, like biosimilars and orphan drugs.
U.S. retail pharmacies only distribute 5% of biologics on the market, according to the AfPA
A staggering 95% of rare diseases have no approved pharmaceutical treatment in certain markets
21 blockbuster biopharmaceutical products, representing $50 billion of annual market value, go off patent between 2009 and 2019
While orphan drugs treat rare diseases for less than 200,000 people in the U.S. according to ISR, the market represents a significant opportunity for biopharma manufacturers